Virginia Clinical Trials

Recruiting studies in Virginia

• A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
  NCT07525206PHASE3AbbVieColorectal CancerBlacksburg, VA
• Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
  NCT07220187PHASE3SWOG Cancer Research NetworkRichter SyndromeRichmond, VA
• A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
  NCT07431177PHASE2Novartis PharmaceuticalsNon-segmental VitiligoNorfolk, VA
• Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation
  NCT07615049PHASE3SWOG Cancer Research NetworkRecurrent Soft Tissue Sarcoma of the Trunk and ExtremitiesRichmond, VA
• Genome Transplant Dynamics
  NCT02423070National Heart, Lung, and Blood Institute (NHLBI)Thoracic Organ TransplantationFalls Church, VA
• A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity
  NCT06830863PHASE1, PHASE2Azitra Inc.EGFR Inhibitor-associated RashFairfax, VA
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
  NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerCharlottesville, VA
• Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
  NCT06581432PHASE2Boehringer IngelheimSolid TumoursFairfax, VA
• A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
  NCT05947851PHASE3Merck Sharp & Dohme LLCLeukemia, Lymphocytic, Chronic, B-CellCharlottesville, VA
• Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
  NCT07661056PHASE3Biohaven Therapeutics Ltd.Graves DiseaseMidlothian, VA
• A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
  NCT07412470PHASE2, PHASE3SanofiKidney Transplant RejectionRichmond, VA
• A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
  NCT07278336PHASE1AbbVieOvarian CancerFairfax, VA

See all 1,925 recruiting trials →

Clinical trials by Virginia metro

• Richmond

Popular conditions in Virginia

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Virginia?

Corterve aggregates actively recruiting clinical trials with sites in Virginia from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in Virginia free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in Virginia?

Virginia research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.